The Bombay High Court has pulled up Maharashtra FDA over its action against Cadila Pharmaceuticals.
The court stressed that regulatory powers must be exercised judiciously and through proper legal procedure.
It also highlighted the importance of ensuring that patients do not suffer due to restrictions on medicine availability.
The FDA has agreed to follow due process before taking further action.
What exactly did the court tell Maharashtra FDA?
The copyright ownership in the video rests with India Today Group. No third party is permitted to use the video without obtaining the permission of India Today Group. Any permission for usage can be obtained through the email ID provided here: mail@lallantop.com.
न्यूज़ लेटर के लिए क्लिक करें : https://www.thelallantop.com/newsletter
खबरों को विस्तार से पढ़ने के लिए क्लिक करें यहां : https://www.thelallantop.com/
Follow us on Facebook: https://www.facebook.com/thelallantop
Follow us on X: https://x.com/TheLallantop
Follow us on Instagram: https://www.instagram.com/thelallantop/
Production: Ritu
Video Editor: Danish
